ro5 drug like natural product library

A unique collection of 2703 natural product monomers that meet the Lipinski's Rule of Five , a powerful tool for HTS and HCS screening;

A unique collection of 500 natural alkaloids can be used for high throughput and high content screening；

A unique collection of 1729 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 4533 pure natural products and their derivatives with known biological activity for drug discovery, pharmacological study, stem cell differentiation, fingerprint study and quality research, and can be used for high throughput screen

A unique collection of 595 saccharides and glycosides compounds can be used for HTS and HCS；

A unique collection of 514 flavonoids can be used for high throughput and high content screening；

A unique collection of 622 natural terpenes and terpenoids can be used for high throughput and high content screening；

A unique collection of 4630 approved and clinical drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 144 marine natural products for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 3840 natural products for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 1074 species of natural products with anti-infective activity for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 635 natural polyphenolic compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 2808 approved drugs for high throughput screening (HTS) and high content screening (HCS);

3158 compounds from marketed drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 1779 approved anti-cancer drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 16627 pure natural products with diverse structures and sources covering various plant, animal, and microbe species;

A unique collection of 685 microbial natural products for high throughput screening (HTS) and high content screening (HCS);

The library consists of more than 4,000 members belonging 22 scaffolds (average 180 compounds per scaffold).

Detialed biological information and pharmacological information of the products, providing theoretical direction and research basis for screening.

A unique collection of 2051 natural products included in Chinese Pharmacopoeia (CP), a powerful tool for drug development and pharmacological study;

A unique collection of 1812 natural products with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 972 pediatric drugs for high-throughput screening and high-content screening.

A unique collection of 693 rare natural products, which can be used for high throughput screening (HTS) and high content screening (HCS);

1119 drug fragments，a must-have tool for FBDD;

A unique collection of 197 drug isomers metabolites for high throughput screening (HTS) and high content screening (HCS);

48 Chemotherapeutic drugs that can be used for high-throughput and high-content screening.

Large quantity: contains 163,000 natural product derivatives and the number is continuously updating;

119 tumor-targeted drugs that can be used for high-throughput and high-content screening.

A unique collection of 253 natural products with antiparasitic activity, a powerful tool for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 3080 anticancer drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 219 natural products related to gastroenteritis for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 1001 hepatotoxicity causing compounds, a powerful tool for drug toxicity study, can be used for HTS and HCS screening；